-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED ANNOUNCES SOVLEPLENIB GRANTED US FDA ORPHAN DRUG DESIGNATION FOR AUTOIMMUNE HEMOLYTIC ANEMIA

Reuters·11/05/2026 00:00:00

Please log in to view news